Clinical Trial

HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers

Study acronym: HypnoDA
Recruiting
View on ClinicalTrials.gov →
Summary
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-11-03; most recent amendment 2025-09-08.
Status change: Not Yet Recruiting → Recruiting 2024-11-19
Trial Details
NCT Number NCT05611346
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Conditions Dermatitis
Enrollment 32 participants
Start Date 2024-08-13
Primary Completion 2027-02 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-12